Medesthetics Special

ACNE & ROSACEA 2013

Surgical Aesthetics and Acne & Rosacea are special editions of Medesthetics. To see Surgical Aesthetics, go to http://surgicalaestheticsmagazine.epubxp.com

Issue link: https://medesthetics.epubxp.com/i/139907

Contents of this Issue

Navigation

Page 5 of 23

Accutane (isotretinoin) is considered the gold standard for reducing lesions in patients with moderate-to-severe acne. Its ability to inhibit sebum production has provided relief to many, but its well-publicized—and serious—side effects have left the public and many physicians wary of using the drug. The good news for dermatologists and skincare specialists is that these concerns have launched a new wave of research that includes devices, topicals and injectables aimed at finding a safe, non-systemic option for sebum control. for Sebum Control By Inga Hansen 4 July/August 2013 | ACNE & ROSACEA The search for a nonsystemic treatment to reduce oil production in the skin has led to a number of promising discoveries. © istockphoto.com Emerging Tools

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics Special - ACNE & ROSACEA 2013